Current Urology最新文献

{"title":"Transcription factor E3 renal cell carcinoma presenting as secondary hypertension.","authors":"Alain Mwamba Mukendi,&nbsp;Gerald Tatenda Mataruka,&nbsp;Ramesh Nadimpalli,&nbsp;Tshisola Miji Kasapato","doi":"10.1097/CU9.0000000000000108","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000108","url":null,"abstract":"<p><p>Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most common presenting symptoms being hematuria, pain, and abdominal mass, or paraneoplastic event. In conventional RCCs, hypertension is considered a risk factor and a possible paraneoplastic event, whereas, in translocation RCCs, prior exposure to cytotoxic chemotherapy is the only known risk factor, and hypertension as an isolated associated paraneoplastic event has never been reported. Interestingly, hypertension as the only presenting symptom in RCC is extremely rare. We report a case of transcription factor E3 positive RCC in a young adult presenting only with hypertension that normalized after radical nephrectomy. To the best of our knowledge, this is the first reported case of hypertension secondary to microphthalmia-associated transcription translocation RCC.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"58-61"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/5d/curr-urol-17-58.PMC10487286.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10569902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A rare triple concurrence of ureteric calculus and renal cell carcinoma in a horseshoe kidney.","authors":"Kale Munien,&nbsp;Joshua Winston,&nbsp;Nicholas Davies","doi":"10.1097/CU9.0000000000000179","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000179","url":null,"abstract":"<p><p>Horseshoe kidney is a rare anatomical variant with low clinical morbidity. However, the characteristic shape of horseshoe kidney causes significant anomalies within the vascular and collecting systems. This complicates the diagnosis and management of coexisting pathologies within the kidneys. Here, we report a rare case of concurrent diagnoses of ipsilateral ureteric calculus and renal cell carcinoma within a horseshoe kidney and describe the subsequent management rationale based on the current literature.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"41-44"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d0/d1/curr-urol-17-41.PMC10487285.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10224047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ureteroscopy during pregnancy: Outcomes and lessons learned over 4 decades at a tertiary center in Norway.","authors":"Patrick Juliebø-Jones,&nbsp;Christian Beisland,&nbsp;Peder Gjengstø,&nbsp;Stephen Baug,&nbsp;Øyvind Ulvik","doi":"10.1097/CU9.0000000000000157","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000157","url":null,"abstract":"<p><strong>Background: </strong>The management of suspected kidney stone disease in pregnancy is challenging. In cases of persistent flank pain and where investigations may have rendered equivocal results, ureteroscopy (URS) is a recognized diagnostic and therapeutic intervention. This study aimed to investigate the safety and outcomes associated with performing URS during pregnancy, as the technique has evolved over the past 4 decades at our center.</p><p><strong>Materials and methods: </strong>We performed a retrospective analysis of pregnant patients who underwent URS at our tertiary center between 1984 and 2022. Outcomes of interest included anesthetic approach, operative time, hospital stay, and complications.</p><p><strong>Results: </strong>Eighty-seven pregnant patients underwent 96 URS procedures, and 60% (<i>n</i> = 57) of these procedures were performed during the third trimester. Overall, 58% (n = 56) of the procedures were achieved with local anesthesia and light sedation. During the most recent decade, the latter was successfully carried out in 97% of the procedures, with the remainder occurring under spinal anesthesia as per patient choice. Overall, 57% (n = 50) of the whole study group had ureteral calculi found at the time of surgery and in 88% (n = 44) of these cases, fragmentation/extraction was performed. The remainder had insertion of ureteral stent with definitive clearance deferred until postpartum. Mean operative time and postprocedure hospital stay was 33 minutes (range, 7-100 minutes) and 2.2 days (range, 0-16 days), respectively. The overall intraoperative and postoperative complication rates were 2% and 11%, respectively. During the final decade, the latter improved to 6% and all adverse events were minor (Clavien I/II), with the exception of a single case. Regarding exit strategy, ureteral stent was placed in 42% (n = 40) of the procedures, 23% (n = 22) had ureteral catheter inserted, and the remainder (35%, n = 34) had none.</p><p><strong>Conclusions: </strong>Ureteroscopy can be safely performed during pregnancy using anesthetic approach with local anesthesia and light sedation. Development of a local protocol and multidisciplinary management algorithm are instrumental in enabling the delivery of such a service.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"7-12"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5e/fd/curr-urol-17-07.PMC10487287.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10275564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of urolithiasis in pregnancy.","authors":"Kimberley Chan, Taner Shakir, Omar El-Taji, Amit Patel, John Bycroft, Chou Phay Lim, Nikhil Vasdev","doi":"10.1097/CU9.0000000000000181","DOIUrl":"10.1097/CU9.0000000000000181","url":null,"abstract":"<p><p>Urolithiasis is the most common cause of nonobstetric abdominal pain, resulting in 1.7 admissions per 1000 deliveries. Urolithiasis most commonly occurs in the second and third trimesters, with an incidence between 1:125 and 1:2000. Acute urinary system obstructions are challenging to manage in obstetric patients because they contribute to physiological and anatomical changes that result in pathological outcomes. The restricted use of computed tomography in diagnosing and managing urolithiasis is particularly challenging. In addition, a prompt diagnosis is required because the presence of renal calculi during pregnancy increases the risk of fulminating sepsis and preterm delivery. Affected pregnancies are conservatively managed; however, 1 in 4 requires surgical intervention. Indications for surgical interventions are complex and range from nephrostomy insertion to empirical stent placement or ureteroscopy. Therefore, a multidisciplinary approach is required to optimize patient care. The diagnosis and management of urolithiasis in pregnancy are complex. We reviewed the role, safety, advantages and disadvantages of diagnostic tests and treatment used to manage acute urinary obstructions in pregnancy.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"1-6"},"PeriodicalIF":0.9,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/57/curr-urol-17-01.PMC10487296.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10221801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Aquablation in men with benign prostate hyperplasia: A systematic review and meta-analysis.","authors":"David C Chen,&nbsp;Liang Qu,&nbsp;Howard Webb,&nbsp;Kirby Qin,&nbsp;Bodie Chislett,&nbsp;Alan Xue,&nbsp;Sari Khaleel,&nbsp;Manuel De Jesus Escano,&nbsp;Eric Chung,&nbsp;Ahmed Adam,&nbsp;Damien Bolton,&nbsp;Marlon Perera","doi":"10.1097/CU9.0000000000000122","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000122","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study is to investigate improvements in lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH) treated with prostatic Aquablation.</p><p><strong>Materials and methods: </strong>We performed a literature search of clinical trials using the MEDLINE, Embase, and Cochrane Library databases and retrieved published works on Aquablation for the treatment of BPH up to August 2021. Unpublished works, case reports, conference proceedings, editorial comments, and letters were excluded. Risk of bias was assessed using the ROBINS-I tool. Raw means and mean differences were meta-analyzed to produce summary estimates for pre- versus post-International Prostate Symptom Scores, maximum flow rate, and male sexual health questionnaire value changes. An inverse-variance weighted random effects model was used.</p><p><strong>Results: </strong>Seven studies were included in this review (n = 551 patients) that evaluated various urological parameters. At 3 months, the International Prostate Symptom Scores raw mean difference from baseline was -16.475 (95% confidence interval [CI], -15.264 to -17.686; <i>p</i> < 0.001), with improvements sustained for 12 months. Similarly, maximum flow rate improved by +1.96 (95% CI, 10.015 to 11.878; <i>p</i> < 0.001) from pre to 3 months postoperatively. In addition, the male sexual health questionnaire change pooled effect size was -0.55 (95% CI, -1.621 to 0.531; <i>p =</i> 0.321) from preintervention to postintervention at 3 months. Meta-analyses of some outcomes showed large statistical heterogeneity or evidence of publication bias.</p><p><strong>Conclusions: </strong>Aquablation seems to improve lower urinary tract symptoms in men with BPH while providing relatively preserved sexual function. Further research is required to confirm these preliminary results.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"68-76"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6a/c2/curr-urol-17-68.PMC10487298.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10275568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The efficacy and safety of one-stage endoscopy combined with intrarenal surgery (mini-nephrostomy tract) in the prone split-leg position for complex renal calculi.","authors":"Kai Yu,&nbsp;Zhebin Du,&nbsp;Hanqing Xuan,&nbsp;Yang Cao,&nbsp;Hai Zhong,&nbsp;Fangzhou Li,&nbsp;Qi Chen","doi":"10.1097/CU9.0000000000000148","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000148","url":null,"abstract":"<p><strong>Background: </strong>The goal of this study was to determine the safety and efficacy of endoscopic combined intrarenal surgery (ECIRS) performed in the prone split-leg position for the treatment of complex renal stones.</p><p><strong>Materials and methods: </strong>A mature ECIRS protocol was designed. Retrospective analysis was conducted of medical records between January 2020 and December 2021 of patients with complex renal stones at one center who underwent ECIRS by 2 skilled surgeons using retrograde flexible ureteroscopy and mini-percutaneous nephrolithotomy in the prone split-leg position.</p><p><strong>Results: </strong>A total of 44 patients were included in this study. Mean stone size was 26.1 ± 12.7 mm, and the number of calyces involved was 4.36 ± 2.09. Mean operative time was 71.1 ± 21.8 minutes. Postoperative decline in hemoglobin was 15.8 ± 9.8 g/L. Seventy-five percent of patients achieved stone-free status. The mean number of residual stones was 2.8 ± 2.3, and the mean residual stone size was 10.30 ± 4.76 mm. Six patients (13.6%) developed postoperative complications, including 4 with fever during the first 2 days postoperatively and 2 patients with transient postoperative pain. No patients developed severe complications.</p><p><strong>Conclusions: </strong>Endoscopic combined intrarenal surgery in the prone split-leg position can be performed safely by experienced surgeons using retrograde flexible ureteroscopy in conjunction with mini-percutaneous nephrolithotomy as a successful technique for the treatment of complex renal stones.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"13-17"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/00/a6/curr-urol-17-13.PMC10487290.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10221803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma.","authors":"Jun Teishima,&nbsp;Daiki Murata,&nbsp;Kazuma Yukihiro,&nbsp;Yohei Sekino,&nbsp;Shogo Inoue,&nbsp;Tetsutaro Hayashi,&nbsp;Koji Mita,&nbsp;Yasuhisa Hasegawa,&nbsp;Masao Kato,&nbsp;Mitsuru Kajiwara,&nbsp;Masanobu Shigeta,&nbsp;Satoshi Maruyama,&nbsp;Hiroyuki Moriyama,&nbsp;Seiji Fujiwara,&nbsp;Akio Matsubara","doi":"10.1097/CU9.0000000000000105","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000105","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to clarify the significance of therapeutic timing on the effectiveness of nivolumab for treating metastatic renal cell carcinoma.</p><p><strong>Marterials and methods: </strong>Fifty-eight patients with metastatic renal cell carcinoma treated with nivolumab monotherapy were retrospectively studied. Patients who were treated with nivolumab as second-line therapy were included in the second-line group, while the others were included in the later-line group. The clinicopathological characteristics, effects of nivolumab, and prognoses of these groups were compared.</p><p><strong>Results: </strong>Twenty and thirty-eight patients were included in the second-line and later-line groups, respectively. There were no significant differences in the distribution of International Metastatic Renal Cell Carcinoma Database Consotium risk and other clinicopathological characteristics between the 2 groups. The proportion of patients whose objective best response was progressive disease in the second-line group was significantly lower than that in the later-line group (15% vs. 50%, <i>p</i> = 0.0090). The 50% progression-free survival with nivolumab in the second-line group was significantly better than that in the later-line group (not reached and 5 months, <i>p</i> = 0.0018). Multivariate analysis showed that the second-line setting was an independent predictive factor for better progression-free survival (<i>p</i> = 0.0028, hazard ratio = 0.108). The 50% overall survival after starting nivolumab in the second-line and later-line groups was not reached and 27.8 months, respectively (<i>p</i> = 0.2652).</p><p><strong>Conclusions: </strong>The therapeutic efficacy of nivolumab as second-line therapy is expected to be better than that of later therapy.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"52-57"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/95/curr-urol-17-52.PMC10487289.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10224050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metabolic evaluation of first-time uncomplicated renal stone formers: A prospective study.","authors":"Satish Kumar Ranjan,&nbsp;Ankur Mittal,&nbsp;Anissa Atif Mirza,&nbsp;Sunil Kumar,&nbsp;Vikas Kumar Panwar,&nbsp;Shivcharan Navriya,&nbsp;Arup Kumar Mandal,&nbsp;Kim Jacob Mammen","doi":"10.1097/CU9.0000000000000169","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000169","url":null,"abstract":"<p><strong>Background: </strong>Nephrolithiasis is a global health problem. The recurrence rate after the first stone clearance is approximately 50% at 5 years. Metabolic abnormalities are an important factor responsible for stone recurrence. Our prevalidated study aimed to evaluate metabolic abnormalities associated with first-time uncomplicated renal stone formers (FTURSF).</p><p><strong>Materials and methods: </strong>In this prospective, exploratory, time-bound, descriptive study, 30 first-time renal stone formers were evaluated for metabolic abnormalities. High-risk stone formers were excluded from the study. Data were collected in a predefined proforma, transferred to an Excel sheet, and analyzed using the Statistical Package for Social Sciences 20 and Epi Info 7. Fisher exact test, Mann-Whitney <i>U</i> test, paired <i>t</i> test, and Pearson correlation coefficient were used for statistical analyses.</p><p><strong>Results: </strong>The mean age of the participants was 35.57 ± 11.07 years, with a male-to-female ratio of 1.72. The most common abnormality was a 24-hour urine volume of <2.5 L in 73.33% of the participants. One or more metabolic abnormalities were detected in 76.67% of the participants. Other common metabolic abnormalities detected were hypocitraturia (60%), hypercalciuria (16.67%), hyperoxaluria (13.33%), and hyperuricosuria (3.33%). Parathyroid adenoma was detected in one participant (3.33%).</p><p><strong>Conclusions: </strong>Our study documented significant metabolic abnormalities in FTURSF. Therefore, a simplified metabolic evaluation protocol should be adopted while evaluating FTURSF. Detection of an underlying metabolic abnormality would enable the early institution of preventive measures to reduce stone recurrence and related complications.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"36-40"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/df/curr-urol-17-36.PMC10487292.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10275563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of lemon-tomato juice consumption on crystal formation in the urine of patients with calcium oxalate stones: A randomized crossover clinical trial.","authors":"Sathish K Gopala,&nbsp;Jim Joe,&nbsp;Jithesh Chandran","doi":"10.1097/CU9.0000000000000178","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000178","url":null,"abstract":"<p><strong>Background: </strong>Dietary supplementation with citrate-containing juices may serve as an effective alternative to potassium citrate therapy for preventing calcium oxalate stone recurrence. This study was performed to evaluate whether consumption of lemon-tomato juice can decrease the tendency for stone formation in the urine of calcium oxalate stone formers.</p><p><strong>Materials and methods: </strong>The study was conducted as a prospective interventional randomized crossover clinical trial with a repeated-measures design. Twenty-two patients with calcium oxalate stones and no metabolic abnormalities in the urine treated with lithotripsy at a tertiary care center from August 2017 to July 2018 were recruited. After a 14-hour overnight fasting, urine samples were collected after the patients consumed either milk only or milk and lemon-tomato juice. Their urine was tested for multiple parameters, including urine pH, specific gravity, calcium-creatinine ratio, and supersaturation with sodium oxalate, followed by optical density measurement via spectrophotometry.</p><p><strong>Results: </strong>There were no significant differences in the background characteristics between the 2 groups. The optical density of the urine samples obtained after consumption of milk only was significantly higher than that after consumption of milk and lemon-tomato juice (mean = 0.131 for milk only vs. 0.053 for milk and lemon-tomato juice, <i>p</i> < 0.001). The urine calcium-creatinine ratio was similar between the groups (mean = 0.141 for milk only vs. 0.076 for milk and lemon-tomato juice, <i>p</i> = 0.019).</p><p><strong>Conclusions: </strong>The addition of lemon-tomato juice as a source of citrate in the diet significantly decreases the established risk factors for calcium oxalate stone formation in patients. This study was prospectively registered at CTRI under number CTRI/2017/04/008312 on April 7, 2017.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"25-29"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/76/db/curr-urol-17-25.PMC10487295.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10275567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of the efficacy of reduced-radiation noncontrast computed tomography scan compared with the standard noncontrast computed tomography scan for detecting urolithiasis: A prospective single-center study.","authors":"Gaurav Aggarwal,&nbsp;Samiran Das Adhikary","doi":"10.1097/CU9.0000000000000162","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000162","url":null,"abstract":"<p><strong>Background: </strong>Noncontrast computed tomography (CT) scan of the kidneys, ureter and bladder is the standard investigative modality for diagnosing and following up patients with urolithiasis. With each scan, a patient receives radiation of 18-34 mGy. Dose considerations become pertinent because of a 10% lifetime incidence rate and higher than 50% risk of recurrence, necessitating repeated imaging in the lifetime of a stone former. Hence, this study aimed to assess the sensitivity of \"reduced-radiation\" CT imaging by altering scan settings to lower than the \"standard\" norms.</p><p><strong>Materials and methods: </strong>Altogether, 222 patients (255 \"kidney-ureter\" stone-bearing units or \"renal units\") with urolithiasis and patients undergoing CT for other reasons with incidental findings of renal/ureteric calculi between 2017 and 2019 were included. All patients were subjected to 3 sequential scans at tube current settings of 250 mA (CT-N/Standard), 100 mA (CT-100), and 50 mA (CT-50) at a constant voltage of 120 kV. Their clinicodemographic and radiological findings were recorded and assessed for significance.</p><p><strong>Results: </strong>Of the 255 renal units, 117 were between 30 and 44 years of age, 75% were men. Of the 255 patients, 178 (70.1%) reported a first stone episode and 77 had recurrence. Lower ureteric calculi were predominant (40.4%). All calculi were identified on CT-N; CT-100 failed to detect calculi in 1 patient, and CT-50 failed in 3 patients, where all calculi were <3 mm in size. Meanwhile, none were undetected among patients with obesity. The sensitivity was 99.61% for the CT-100 and 98.82% for the CT-50, which indicated a 2.5 and 5 times lower radiation and dose/length, respectively, than CT-N.</p><p><strong>Conclusions: </strong>The reduced-radiation CT scan is safe, sensitive, and accurate for the diagnosis and follow-up of patients with urolithiasis with significantly lower radiation exposures. Our study lays the foundation to accept low-dose CT in general and CT-50 in particular, as the new \"standard of care,\" and attempt further dose reduction without loss of diagnostic efficacy.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"17 1","pages":"18-24"},"PeriodicalIF":1.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9c/d0/curr-urol-17-18.PMC10487294.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10224043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}